Cancer Neuroscience Symposium
Event Description
Date & Location
Wednesday, February 28, 2024, 1:00 PM - Friday, March 1, 2024, 5:00 PM, MD Anderson - Mitchell Building, Houston, TX
Target Audience
Specialties - Neurology
Professions - Other, Student or Trainee
Credits
Non-Accredited (1.00 hours)
MD Anderson Cancer Center presents a two-day hybrid symposium featuring contributions from over 30 leading international experts focused on Cancer Neuroscience. Be part of a groundbreaking scientific event that will integrate neuroscience, cancer biology and aging science to spur a wave of innovation in cancer research and care. Building on our previous meeting with over 1200 participants as well as collaborative research and discussion among our speakers, the goal of this meeting is to explore how the interface between cancer biology and neuroscience impacts tumor development, progression and health outcomes.
This 2nd Cancer Neuroscience Symposium will leverage advances in neuroscience, as well as advances in immuno-oncology and aging. This meeting will cover emerging areas, such as neuro-immune interactions, plasticity within the tumor microenvironment, and translational research. This meeting will bring together leading experts from across the fields of neuroscience, cancer biology, immunology, and the biology of aging, as well as oncologists, surgeons, neurologists, patients and patient advocates to facilitate discussions of exciting new concepts and developments in this rapidly growing field.
CNS 2024: Satellite Meeting on Clinical Cancer Neuroscience
The 2024 Satellite Meeting of the Cancer Neuroscience Symposium will be held virtually on February 28, 2024. Talks will present translational and clinical innovations in cancer neuroscience. Speakers will discuss advances in neurotoxicities during cancer therapies, mental health and pain effects from cancer and cancer therapies, a clinical trial panel, and a meet the editor session. The satellite meeting aims to cross-fertilize the breadth of cancer neuroscience presented at the primary cancer neuroscience symposium.
Objectives
At the conclusion of this activity, learners will be able to:
- Summarize interactions between cancer and the nervous system;
Discuss neuro-cancer crosstalk (mediators, mechanisms, and outcomes) in the central and peripheral nervous systems;
Understand neurotoxicities and nervous system health during cancer therapy; and
Describe novel concepts in targeting neuro-immune crosstalk in the central and peripheral nervous systems and their translational impact.
Registration
The Cancer Neuroscience Symposium 2024 Registration is Now Open! Register soon, there are only 220 in person seats available each day! The Symposium will begin at 7:30 AM on Thursday February 29, 2024 and will adjourn at 4:00 PM on Friday, March 1, 2024. Advanced registration is encouraged please see registration information below for applicable fees.
Day 1
Sessions will delve into novel findings in fundamental research of the nervous system and cancer biology. We will highlight our special focus on the interaction of cancer and aging biology, including neurodegeneration. Attendees should gain insights into fundamental research that addresses contributing and causative factors that can hijack or hamper these basic biological processes.
Speakers: Michelle Monje-Deisseroth, Elizabeth A. Repasky, Frank Winkler, Gustavo Ayala, Brian Davis, Moran Amit, Monty Montano, and Pre-offered abstracts
Focus Area Speakers: Shane Liddelow, Jorg Dietrich, Benjamin Deneen, Derek Wainwright
Day 2
Breakout Symposium: Central Nervous System
This session will examine current findings into the interplay between the central nervous system and cancer biology. The CNS Breakout Symposium features 5 breakout sessions:
1) Neuronal Regulation of Primary CNS Cancer; 2) Neuronal Regulation of CNS Metastasis; 3) Influence of CNS Cancer on Neuronal Activity; 4) Cancer Therapy Induced CNS Impairments; and 5) Modeling Brain Tumor and TME Interactions.
Attendees should gain insights into fundamental research that addresses contributing and causative factors that can hijack or hamper these basic biological findings.
Speakers: Varun Venkataramani, David Gutmann, Kathryn Taylor, Adrienne Boire, Humsa Venkatesh, Manuel Valiente, Shawn Hervey-Jumper, Harald Sontheimer, Erin Gibson, Munjal Acharya, Donald Mabbott, Joshua Breunig, Hui Zong, Suzanne Baker, Vinay Puduvalli, and Yuan Pan.
Breakout Symposium: Peripheral Nervous System
This session will examine current foundational research findings into the interactions between peripheral nerves and tumors. Speakers will discuss
1) The Interactions and Impact of Nerves on Cancer, Stromal and Immune Cells, and 2) The Role of Tumor Cells in Facilitating the Recruitment and Function of Peripheral Neural, Glial and Immune Cells that in Turn Modulate Cancer Progression and Outcomes.
Attendees should gain insights into the cellular interactions in the neural tumor microenvironment that drive cancer growth and progression in peripheral tumors.
Speakers: Paola Vermeer, Rohini Kuner, William Hwang, Yuri Bunimovich, Sébastien Talbot, Jami Saloman, Fanny Mann, Nicole Scheff, Richard Wong, Timothy Wang, Faranak Fattahi, Ruth White, Moran Amit, Ekin Demir and Nisha D’Silva.
After the Cancer Neuroscience Symposium, we hope that you can easily see how multidimensional and interdisciplinary efforts will integrate and cross- fertilize these themes toward larger aspirational goals.
Registration Fees:
The Cancer Neuroscience Symposium is a two-day hybrid symposium, on-site and virtual options, presented by The University of Texas MD Anderson Cancer Center. Registration for on-site participation is limited to 240 seats and the subsided in-person registration fee is $90 for early bird, and $150 thereafter.
We understand that everyone's financial situation is different, and we want to ensure that cost is not a barrier to participating in this incredible event. With our "Pay As You Wish" virtual registration option, you are able to choose the virtual registration fee that best fits your budget. Whatever dollar amount you wish to contribute, the decision is entirely up to you. We appreciate any amount that you can offer, as it helps support the symposium and it enables us to continue planning enriching educational experiences for all attendees.
Please select the registration fee that is appropriate for you.
Pay As You Wish Fee Structure (Virtual)
Pay As You Wish - $0.00
Pay As You Wish - $48.00
Pay As You Wish - $96.00
Pay As You Wish - $148.00
Pay As You Wish - $199.00
On-Site Registration (In Person) (Limited Seating) Only 240 seats available
In Person Attendance Fee - $90.00 (Before October 13, 2023)
In Person Attendance Fee - $150.00 (After October 13, 2023)
CNS 2024: Satellite Meeting on Clinical Cancer Neuroscience - February 28, 2024, Wednesday @ 1:00 - 4:30 p.m. (Optional)
Planning Committee
Moran Amit, MD, PhD
Conference Chair
UT MD Anderson Cancer Center
Brandi Mattson, PhD
Organizing Committee Chair
UT MD Anderson Cancer Center
Monty Montano, PhD
Organizing Committee Chair
Harvard Medical School
Brigham and Women’s Hospital
Antentor Othrell Hinton, Jr., PhD
Organizing Committee Chair DEI
Baylor Collage of Medicine
The Vanderbilt Diabetes Research
and Training Center
Nisha D'Silva, BDS, MSD, PhD
Organizing Committee Chair
University of Michigan School of Dentistry
Ekin Demir, MD
Technical University of Munich
William L. Hwang, MD, PhD
Assistant Professor
Harvard Medical School/Massachusetts
General Hospital
Yuan Pan, PhD
Assistant Professor
UT MD Anderson Cancer Center
Vinay Puduvalli, MD
Professor
UT MD Anderson Cancer Center
Nicole Scheff, PhD
Assistant Professor
University of Pittsburgh
Additional Information
View the accessibility policy for The University of Texas M.D Anderson Cancer Center.
Event Site Link
https://mdanderson.cloud-cme.com/course/courseoverview?P=0&EID=24473